Malignant histiocytosis. Response to VP-16-213 and cytosine arabinoside.

Abstract	A patient with malignant histiocytosis who relapsed after receiving an Adriamycin (doxorubicin)-containing combination and radiation therapy subsequently had a complete remission on VP-16-213 and cytosine arabinoside. She remains free of disease 32 months after achieving a complete remission. VP-16-213 and cytosine arabinoside (Ara-C) deserve further evaluation in the treatment of this neoplasm.
Authors	R Vera Jr, J R Bertino, E Cadman, J A Waldron
Journal	Cancer (Cancer) Vol. 54 Issue 6 Pg. 991-3 (Sep 15 1984) ISSN: 0008-543X [Print] United States
PMID	6467142 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References	Cytarabine Etoposide Podophyllotoxin
Topics	Aged Cytarabine (administration & dosage) Etoposide (administration & dosage) Female Humans Lymph Nodes (pathology) Lymphatic Diseases (drug therapy, pathology) Podophyllotoxin (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!